September 2024: Listed on the US Nasdaq Market! The Medical Group Supporting Shonan Beauty Clinic’s Growth Challenges the International Stage! – Diamond Online

News Highlights

The medical group operating Shonan Beauty Clinic was listed on the US Nasdaq market in September 2024. This is a rare case of a domestic medical institution challenging the international stage, demonstrating the group’s growth strategy and ambition for global expansion. According to reports, this listing suggests new possibilities for medical M&A and business succession.

Perspective from the M&A Medical Editorial Department

The Nasdaq listing of Shonan Beauty Clinic is more than just a successful fundraising case. It is groundbreaking in that it demonstrates the potential for domestic medical institutions to be recognized in the global market. In particular, the growth potential of the aesthetic medicine market, along with the organizational strength and brand power supporting it, are thought to have attracted the interest of international investors. This case presents not only the option of “third-party succession within Japan” to medical institution managers struggling with lack of successors, but also the possibility of a more dynamic business succession and growth strategy: “business expansion and IPO (Initial Public Offering) with a view to the global market.” While an IPO has a high hurdle, the process of aiming for it can lead to strengthening the organizational structure, establishing governance, and improving the financial base, potentially making it easier to secure more favorable terms in domestic M&A as a result.

Points Raised by This News

• The Nasdaq listing of Shonan Beauty Clinic suggests the potential for domestic medical institutions to be evaluated in the global market.
• The growth of the aesthetic medicine sector and organizational strength are presumed to be factors that attracted international investors’ interest.
• An IPO can be an alternative or complementary business succession and growth strategy to domestic third-party succession.
• The IPO preparation process, through organizational strengthening and financial improvements, may enhance negotiation power in domestic M&A.

Practical Questions Arising from This News

• What were the specific processes of organizational strengthening and financial improvement leading up to the Nasdaq listing?
• What kind of expert support (securities firms, lawyers, accountants, etc.) was essential in aiming for an IPO?
• Is a business strategy with a global market in mind possible even for local clinics in Japan?

If You Feel “Should I Consult Too?”

It may be time to organize your clinic’s management status, future vision, and whether you have successor candidates, and consider with experts whether a business succession and growth strategy that includes global expansion and IPOs, like Shonan Beauty Clinic’s, is realistic, or if domestic M&A or third-party succession is more suitable. Please consult with us once to find the option that maximizes your clinic’s potential.

M&A Medical (CentralMedience Inc.) supports the business succession of medical corporations, hospitals, and clinics as a business succession support institution certified by the Small and Medium Enterprise Agency, with a complete success fee system. Consultations are kept strictly confidential. Free consultation here